Rho and its downstream target, Rho-associated coiled-coil-containing kinase (ROCK), are mediators of endothelial dysfunction [55], hence their inhibition can improve endothelial function, and decrease vascular inflammation and atherosclerosis [56]. This evidence concerns the gene RHO and endothelial dysfunction.